Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of contact lens maker Cooper Companies
So what: The company's CooperVision subsidiary has expanded its recall of lots of Avaira Toric lenses to also include limited lots of Avaira Sphere lenses. CooperVision is continuing to collaborate with the Food and Drug Administration in implementing the recall. The Avaira Sphere lenses identified don't meet the company's updated quality requirements due to the level of a silicone oil residue. CooperVision plans on replacing the product with available inventory.
Now what: The company had announced a recall in October that covered 600,000 lenses that arose from complaints of severe eye pain. The sell-off has been swift, but possibly overdone, as the total cost of the recall is expected to be around $23.2 million, and last quarter's total revenue was $351.4 million, and net income was $38.1 million. Cooper has already taken $14.2 million of the costs in the third quarter, so it is setting aside a reserve of $9 million to cover the rest. The recall will definitely be pricey, but a 20% haircut is rather extreme.
Interested in more info on Cooper Companies? Add it to your watchlist by clicking here.
Fool contributor Evan Niu holds no position in any company mentioned. Click here to see his holdings and a short bio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.